FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for a lisinopril and hydrochlorothiazide fixed-dose combination from GSMS, Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide)

Snippet

SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)